| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A differential therapeutic consideration for use of corticosteroids according to established COVID-19 clinical phenotypes in critically ill patients
|
Moreno, G.
|
|
|
47 |
1 |
p. 23-33
|
artikel
|
| 2 |
Anticoagulation strategies and risk of bleeding events in critically ill COVID-19 patients
|
Gabara, C.
|
|
|
47 |
1 |
p. 1-8
|
artikel
|
| 3 |
Antiseptic mouthwashes and mortality: look beyond chlorhexidine
|
Blot, S.
|
|
|
47 |
1 |
p. 55-56
|
artikel
|
| 4 |
Aspergiloma y COVID-19
|
Álvarez Fernández, M.
|
|
|
47 |
1 |
p. 62-63
|
artikel
|
| 5 |
Assessment of plasma endocan for the prediction of mortality in COVID-19 patients undergoing veno-venous ECMO: A pilot study
|
Levy, C.
|
|
|
47 |
1 |
p. 51-54
|
artikel
|
| 6 |
¿Cómo y cuándo emplear un dispositivo para eliminación de CO2?
|
de Pablo, R.
|
|
|
47 |
1 |
p. 45-47
|
artikel
|
| 7 |
Cánula fantasma tras retirada de ECMO
|
Martínez-Solano, J.
|
|
|
47 |
1 |
p. 60-61
|
artikel
|
| 8 |
Lung ultrasound protocol decreases radiation in newborn population without side effects: A quality improvement project
|
Rodriguez-Fanjul, J.
|
|
|
47 |
1 |
p. 16-22
|
artikel
|
| 9 |
Multicenter validation of Early Warning Scores for detection of clinical deterioration in COVID-19 hospitalized patients
|
Huespe, I.A.
|
|
|
47 |
1 |
p. 9-15
|
artikel
|
| 10 |
Myocardial injury as a prognostic factor in critically ill patients with severe SARS-Cov-2 pneumonia
|
Villavicencio, C.
|
|
|
47 |
1 |
p. 48-51
|
artikel
|
| 11 |
Reply to “Antiseptic Mouthwashes and Mortality: Look Beyond Chlorhexidine”
|
Vieira, P.C.
|
|
|
47 |
1 |
p. 56-57
|
artikel
|
| 12 |
Treatment of severe infections caused by ESBL or carbapenemases-producing Enterobacteriaceae
|
Lombardi, G.
|
|
|
47 |
1 |
p. 34-44
|
artikel
|
| 13 |
Tromboembolismo pulmonar periférico en neumonía bilateral por COVID-19
|
Vela Colmenero, R.M.
|
|
|
47 |
1 |
p. 58-59
|
artikel
|
Tijdschrift beschrijving